MicroRNA-129-3p Suppresses Tumor Progression and Chemoradioresistance in Head and Neck Squamous Cell Carcinoma

Tae Mi Yoon1, Sun-Ae Kim1, Eun Kyung Jung1

  • 1Departments of Otorhinolaryngology-Head and Neck Surgery, Chonnam National University Medical School, Hwasun Hospital, Hwasun 58128, Jeonnam, Republic of Korea.

PubMed

Insights

MicroRNA-129-3p (miR-129-3p) suppresses head and neck cancer progression and enhances chemoradiotherapy resistance. This microRNA was found to be downregulated in patient tumors, suggesting its therapeutic potential.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • MicroRNA-129 (miR-129) is implicated in cancer progression and chemoresistance.
  • miR-129-3p is the primary mature form of miR-129.
  • Its role in head and neck squamous cell carcinoma (HNSCC) progression and treatment resistance requires investigation.

Purpose of the Study:

  • To evaluate the function of miR-129-3p in HNSCC tumor progression.
  • To assess the impact of miR-129-3p on chemoradiotherapy resistance in HNSCC.
  • To determine miR-129-3p expression levels in HNSCC tissues.

Main Methods:

  • Reverse transcription-quantitative polymerase chain reaction (RT-PCR) for gene expression analysis.
  • Western blotting to assess protein levels.
  • Cellular assays including proliferation, apoptosis, invasion, and migration.
  • In vivo studies using a nude mouse xenograft model.

Main Results:

  • Overexpression of miR-129-3p inhibited proliferation, invasion, and migration in HNSCC cell lines (SNU1041, SCC15, SCC25).
  • miR-129-3p induction enhanced apoptosis and sensitized HNSCC cells to radiation and cisplatin treatment.
  • Tumor tissues from HNSCC patients showed lower miR-129-3p levels compared to normal adjacent tissues.
  • In vivo, miR-129-3p overexpression significantly reduced tumor growth in a xenograft model.

Conclusions:

  • miR-129-3p acts as a tumor suppressor in HNSCC.
  • miR-129-3p enhances sensitivity to chemoradiotherapy in HNSCC.
  • These findings support the development of miR-129-3p-based therapeutic strategies for HNSCC.

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
21.2K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
siRNA - Small Interfering RNAs02:30

siRNA - Small Interfering RNAs

Small interfering RNAs, or siRNAs, are short regulatory RNA molecules that can silence genes post-transcriptionally, as well as the transcriptional level in some cases. siRNAs are important for protecting cells against viral infections and silencing transposable genetic elements.
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
16.5K